ALPS Advisors’s Taiwan Liposome Company, Ltd. American Depository Shares TLC Stock Holding History

ALPS Advisors’s Portfolio TLC Stock Details TLC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-50,851	Closed	-$298K	–	1056
2021 Q2	$298K	Buy	+50,851	New	+$291K	﹤0.01%	836

ALPS Advisors's TLC Position: Q3 2021 in Review

ALPS Advisors sold out of Taiwan Liposome Company, Ltd. American Depository Shares (TLC) in Q3 2021, closing a stake of 50,851 shares — an estimated $298K sold.

ALPS Advisors first reported a position in TLC in Q2 2021 and held it in 1 quarter. The position peaked at $298K in Q2 2021. 0 funds tracked by Wall St. Rank hold TLC as of Q3 2021.

ALPS Advisors reported no remaining Taiwan Liposome Company, Ltd. American Depository Shares position as of Q3 2021 after selling out during the quarter.
ALPS Advisors sold 50,851 Taiwan Liposome Company, Ltd. American Depository Shares shares in Q3 2021, an estimated $298K.
ALPS Advisors first reported a position in Taiwan Liposome Company, Ltd. American Depository Shares in Q2 2021 and held it in 1 quarter.
ALPS Advisors's Taiwan Liposome Company, Ltd. American Depository Shares position peaked at $298K in Q2 2021.
0 funds tracked by Wall St. Rank held Taiwan Liposome Company, Ltd. American Depository Shares as of Q3 2021.

Based on ALPS Advisors's 13F filing for Q3 2021, filed 15 Nov 2021.